The FDA is on a roll. It successfully negotiated with the various stakeholder industries to reach agreements on several user fee agreements (UFAs): PDUFA V, MDUFA III, GDUFA 1 and BSUFA 1 -- and ADUFA is up for reauthorization next year.
That is a whole lot of UFAs. (And the acronyms, in case you can’t keep track, apply to Prescription Drugs,...